Here are relevant reports on : oncology-diagnostics-market
-
Veterinary Imaging Market by Product (CT, MRI, Imaging Systems, Imaging Reagents, Imaging Software, Accessories), Animal Type (Small, Large), Application (Oncology, Dentistry), Modality (Portable, Stationary), End User, Region - Global Forecast to 2031
The global veterinary imaging market, valued at US$2.13 billion in 2025, stood at US$2.29 billion in 2026 and is projected to advance at a resilient CAGR of 7.7% from 2026 to 2031, culminating in a forecasted valuation of US$3.33 billion by the end of the period. This growth is driven by several factors, including an increase in pet ownership, rising spending on animal healthcare, a growing demand for early and accurate diagnosis, and advancements in imaging technologies such as digital radiography, ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Photoacoustic Imaging Market by Product (Imaging System, Transducer, Software, Accessories), Technology (Microscopy, Tomography), Type (Preclinical, Clinical), Application (Oncology, Neuro), End User (Hospitals, Academia) & Region Global Forecast to 2029
The global Photoacoustic imaging market, valued at US$75M in 2023, is forecasted to grow at a 5.5% CAGR, reaching US$80M by 2024 and US$105M by 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Drug Discovery Technologies Market by Product (Instruments, Reagents, Software), Technology (HTS, NGS, PCR, AI-based, Lab-on-chip), Process (Target Identification, Validation, Lead Optimization), Therapeutic Area (Oncology, CVD) - Global Forecast to 2030
The Drug Discovery Technologies market, valued at US$28.61 billion in 2024, stood at US$30.58 billion in 2025 and is projected to advance at a resilient CAGR of 11.0% from 2025 to 2030, culminating in a forecasted valuation of US$51.51 billion by the end of the period. The growth of the drug discovery technologies market is driven by the broader use of advanced screening platforms and rising demand for biologics, cell and gene therapies, and RNA-based drugs.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
High Potency APIs Market / HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) & Region - Global Forecast to 2027
The global high potency APIs market growth is primed to transition from $24.5 billion in 2022 to $39.6 billion by 2027, showcasing a strong CAGR of 10.1%. This growth is driven by increasing demand for oncology drugs, advancements in HPAPI manufacturing technologies, and the rising focus on precision medicine.
- Published: May 2022
- Price: $ 4950
- TOC Available:
-
Positron Emission Tomography Market by Product (Standalone PET Systems, PET/CT Systems, PET/MRI Systems), Application (Oncology, Cardiology, Neurology), End User (Hospitals & Surgical Centers, Diagnostic & Imaging Clinics) & Region - Global Forecasts to 2028
The global positron emission tomography market, valued at US$2.3 billion in 2022, stood at US$2.5 billion in 2023 and is projected to advance at a resilient CAGR of 6.6% from 2023 to 2028, culminating in a forecasted valuation of US$3.5 billion by the end of the period. Technological advancements and new product launches in the radiopharmaceuticals and PET systems, coupled with a growing target patient population, are the key factors driving the adoption of PET systems globally.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Surgical Lasers Market by product type (Carbon Dioxide, Argon, Nd:YAG & Diode Lasers), Procedure (Open, Laparoscopic & Percutaneous), & Application (Ophthalmology, Urology, Gynaecology, Dermatology, Dental, Cardiology, & Oncology) - Global forecast to 2021
The global surgical lasers market is projected to grow at a CAGR of 5.1%. The rising demand for surgical lasers can be attributed to the growing prevalence of chronic diseases, technological advancements, increasing incidence and prevalence of targeted diseases, and high prevalence of ophthalmic disorders. In addition, growing preference for minimally invasive surgeries among patients and healthcare professionals is supporting the growth of the surgical lasers market.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Guidewires Market by Material (Nitinol, Stainless Steel, Hybrid), Product (Surgical, Diagnostic (Hydrophilic, Hydrophobic)), Application (Cardiology, Vascular, Neurology, GIT, ENT, Urology, Oncology), End User (Hospital, ASCs) - Global Forecast to 2022
The global guidewires market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%. The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US). Other prominent players present in this market include Cardinal Health (US), Olympus (Japan), Johnson & Johnson (US), B. Braun (Germany), C.R. Bard (US), Teleflex (US), and Angiodynamics (US).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Surgical Ablation Market by Technology (Radiofrequency, Light/Laser, Electrical, Cryoablation, Microwave, Ultrasound, Hydromechanical), Application (Open Surgery, Minimally Invasive, Cosmetic Surgery, Oncology, Cardiovascular, Orthopedic, Urology) - Global Forecast to 2019
The global surgical ablation market is poised to grow at a CAGR of 8.5% during 2014-2019, and is expected to reach a value of ~$1,567.0 Million in 2019. A number of factors such as growing geriatric population, coupled with an increasing population base of cancer and cardiovascular diseases, ongoing technological advancements in the field of ablation devices, growing awareness about benefits of ablation procedures over conventional therapeutic and surgical procedures, and rising number of hospitals and surgical centers are fuelling the growth of the global surgical ablation market. However, high cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are some of the key factors hampering the market growth.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027
The global bioanalytical testing services market growth is primed to transition from $2.9 billion in 2022 to $6.0 billion by 2027, showcasing a strong CAGR of 15.6%. The major factors influencing the growth of the market include the well-established pharmaceutical industry, the strong presence of major service providers, the large number of ongoing clinical trial studies, high R&D expenditure, growth in the biosimilars and generics markets, and the rise in the outsourcing of preclinical, clinical, and laboratory testing services by pharmaceutical and biopharmaceutical companies in the region.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Europe Electrosurgery Market By Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology), End User (Hospitals, Ambulatory Surgical Centers) - Regional Forecast to 2031
The Europe electrosurgery market, valued at USD 2.26 billion in 2024, stood at USD 2.42 billion in 2025 and is projected to advance at a resilient CAGR of 5.3% from 2025 to 2031, culminating in a forecasted valuation of USD 3.31 billion by the end of the period. The growth of the market is driven by the rising surgical volumes, an expanding elderly population, strong healthcare spending, and rapid adoption of advanced, safety-focused energy platforms across hospitals and specialty centers.
- Published: October 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
